CV Pharmacology | Phosphodiesterase Inhibitors
Phosphodiesterase 3 and 4 Inhibition: Facing a Bright Future in Asthma Control | IntechOpen
Cardiac Cyclic Nucleotide Phosphodiesterases: Roles and Therapeutic Potential in Heart Failure | SpringerLink
TAMRA-cAMP PDE IV substrate *Red Fluorescence* | AAT Bioquest
Phosphodiesterases in endocrine physiology and disease in: European Journal of Endocrinology Volume 165 Issue 2 (2011)
Phosphodiesterases as therapeutic targets for respiratory diseases - ScienceDirect
The PDE-Opathies: Diverse Phenotypes Produced by a Functionally Related Multigene Family: Trends in Genetics
Phosphodiesterase Inhibitors ~ Revolution PharmD
![PDF] Phosphodiesterases and subcellular compartmentalized cAMP signaling in the cardiovascular system. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b9342c10a87e123cc3217e27fec833336b570408/4-Figure1-1.png "PDF] Phosphodiesterases and subcellular compartmentalized cAMP signaling in the cardiovascular system. | Semantic Scholar")
PDF] Phosphodiesterases and subcellular compartmentalized cAMP signaling in the cardiovascular system. | Semantic Scholar
SciELO - Brasil - Nonsteroidal anti-inflammatory drugs as potential ecto-nucleotide phosphodiesterase inhibitors Nonsteroidal anti-inflammatory drugs as potential ecto-nucleotide phosphodiesterase inhibitors
A role for phosphodiesterase type-4 inhibitors in COPD? - The Lancet
Phosphodiesterase Inhibitors | Concise Medical Knowledge
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use | Pharmacological Reviews
IJMS | Free Full-Text | The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
Amrinone, cAMP phosphodiesterase inhibitor (CAS 60719-84-8) (ab142259) | Abcam
Cyclic Nucleotide Phosphodiesterases: important signaling modulators and therapeutic targets - Ahmad - 2015 - Oral Diseases - Wiley Online Library
Phosphodiesterase - Wikipedia
PDE-Glo™ Phosphodiesterase Assay
CV Pharmacology | Phosphodiesterase Inhibitors
IJMS | Free Full-Text | Therapeutic Implications for PDE2 and cGMP/cAMP Mediated Crosstalk in Cardiovascular Diseases
Selection of a Promiscuous Minimalist cAMP Phosphodiesterase from a Library of De Novo Designed Proteins | bioRxiv
Phosphodiesterase Inhibitors: What Are They, How Do They Work, What Are They Used For, and More | Osmosis
Phosphodiesterases Catalyze Hydrolysis of cAMP-bound to Regulatory Subunit of Protein Kinase A and Mediate Signal Termination - ScienceDirect
